Steven Cohen's GILD Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 8,808 shares of Gilead Sciences, Inc. (GILD) worth $1.23 M, representing 0.00% of the portfolio. First purchased in 2014-Q4, this long-term strategic position has been held for 39 quarters.
Based on 13F filings, Steven Cohen has maintained a strategic position in GILD, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2018, adding 2.84 M shares. Largest reduction occurred in Q3 2018, reducing 1.92 M shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Gilead Sciences (GILD) Holding Value Over Time
Track share changes against reported price movement
Quarterly Gilead Sciences (GILD) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +8,808 | New Buy | 8,808 | $139.37 |
| Q3 2025 | -164,728 | Sold Out | 0 | $0.00 |
| Q2 2025 | -346,008 | Reduce 67.75% | 164,728 | $110.87 |
| Q1 2025 | -345,921 | Reduce 40.38% | 510,736 | $112.05 |
| Q4 2024 | -1.45 M | Reduce 62.84% | 856,657 | $92.37 |
| Q3 2024 | +1.79 M | Add 350.14% | 2.31 M | $83.84 |
| Q2 2024 | +154,525 | Add 43.21% | 512,125 | $68.61 |
| Q1 2024 | +357,600 | New Buy | 357,600 | $73.25 |
| Q4 2023 | -602 | Sold Out | 0 | $0.00 |
| Q3 2023 | +602 | New Buy | 602 | $75.00 |
| Q2 2023 | -46,585 | Sold Out | 0 | $0.00 |
| Q1 2023 | +46,585 | New Buy | 46,585 | $82.97 |
| Q4 2022 | -562,900 | Sold Out | 0 | $0.00 |
| Q3 2022 | +562,900 | New Buy | 562,900 | $61.69 |
| Q2 2022 | -125,000 | Sold Out | 0 | $0.00 |
| Q1 2022 | +125,000 | New Buy | 125,000 | $59.45 |
| Q2 2021 | -1.81 M | Sold Out | 0 | $0.00 |
| Q1 2021 | +1.2 M | Add 196.25% | 1.81 M | $64.63 |
| Q4 2020 | +612,143 | New Buy | 612,143 | $58.26 |
| Q1 2020 | -402,631 | Sold Out | 0 | $0.00 |
| Q4 2019 | +402,631 | New Buy | 402,631 | $64.98 |
| Q3 2019 | -10,100 | Sold Out | 0 | $0.00 |
| Q2 2019 | +10,100 | New Buy | 10,100 | $67.52 |
| Q1 2019 | -548,917 | Sold Out | 0 | $0.00 |
| Q4 2018 | -698,365 | Reduce 55.99% | 548,917 | $62.55 |
| Q3 2018 | -1.92 M | Reduce 60.66% | 1.25 M | $77.21 |
| Q2 2018 | +92,165 | Add 2.99% | 3.17 M | $70.84 |
| Q1 2018 | +2.84 M | Add 1172.64% | 3.08 M | $75.39 |
| Q4 2017 | +241,904 | New Buy | 241,904 | $71.64 |
| Q3 2017 | -1.27 M | Sold Out | 0 | $0.00 |
| Q2 2017 | +706,810 | Add 124.86% | 1.27 M | $70.78 |
| Q1 2017 | +566,100 | New Buy | 566,100 | $67.92 |
| Q4 2016 | -141,000 | Sold Out | 0 | $0.00 |
| Q3 2016 | -518,100 | Reduce 78.61% | 141,000 | $79.12 |
| Q2 2016 | +658,400 | Add 94057.14% | 659,100 | $83.42 |
| Q1 2016 | +700 | New Buy | 700 | $91.43 |
| Q2 2015 | -1.16 M | Sold Out | 0 | $0.00 |
| Q1 2015 | +96,900 | Add 9.13% | 1.16 M | $98.13 |
| Q4 2014 | +1.06 M | New Buy | 1.06 M | $94.26 |
Steven Cohen's Gilead Sciences Investment FAQs
Steven Cohen first purchased Gilead Sciences, Inc. (GILD) in Q4 2014, acquiring 1,061,100 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Gilead Sciences, Inc. (GILD) for 39 quarters since Q4 2014.
Steven Cohen's largest addition to Gilead Sciences, Inc. (GILD) was in Q1 2018, adding 3,078,566 shares worth $232.09 M.
According to the latest 13F filing for Q1 2026, Steven Cohen's firm, Point72 Asset Management, L.P., owns 8,808 shares of Gilead Sciences, Inc. (GILD), valued at approximately $1.23 M.
As of the Q1 2026 filing, Gilead Sciences, Inc. (GILD) represents approximately 0.00% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Gilead Sciences, Inc. (GILD) was 3,170,731 shares, as reported at the end of Q2 2018.